ESHG 2026 | 13–16 June | Svenska Mässan Hall B | Booth #406
Visit Bio‑Techne Diagnostics at Booth 406 to see how our solutions are engineered to simplify complex workflows, improve reproducibility and confidence in results. Stop by for fast, focused micro‑talks—short sessions with meaningful takeaways.
Join Us at Booth #406 for a Series of Micro-Talks
These brief, in-booth presentations will feature our scientists and product specialists. The micro-talks are designed to share practical insights, highlight software performance, and give attendees the opportunity to connect directly with our experts throughout the conference.
The Evolving Role of Genetic Testing for SMA in The Modern Therapeutic Era
Saturday 13 June / 16:00-16:15
Carrier Screening for Clinically Relevant, Hard-to-Decipher Genes via a Single Long-Read Sequencing-Based Workflow
Sunday 14 June / 12:00-12:15
Streamlining Cancer Surveillance: ESR1 Liquid Biopsy Testing & HemOnc Monitoring
Sunday 14 June / 16:00-16:15
Mapping Thalassemia Genotypes: From Variant Complexity to Clarity
Monday 15 June / 15:30-15:45
Visit Our Poster
Find Out More About Our Thalassemia Assay in Development
Resolution of Rare and Complex Thalassemia Genotypes in a Single Workflow Using Long-Range PCR and Long-Read Sequencing
Poster No.: P21.022D
Session Date: 14 June
Time: 15:45–16:45
Cody Edwards
Scientist, Bio-Techne Diagnostics
Portfolio Spotlight
AmplideX® Nanopore Carrier Plus Kit*
AmplideX® Nanopore Carrier Plus Kit*
A Long-Range PCR & Long-Read Sequencing Solution for Carrier Screening Research
The AmplideX Nanopore Carrier Plus Kit interrogates eleven genes that contribute to high-risk couple rates in carrier screening. The design utilises four mixes across the 11 genes with modularity to allow any combination of testing.
AmplideX® PCR/CE Assays
Complex genetic testing made simple in inherited genetic disorders linked to hard-to-decipher genes.
QuantideX® qPCR ESR1 exoMutation Kit*
QuantideX® qPCR ESR1 exoMutation Kit*
Balancing High-Sensitivity with High-Specificity for ESR1 Mutation Detection
The QuantideX qPCR ESR1 exoMutation Kit is the first multianalyte liquid biopsy assay tailored for detecting ESR1 mutations. Designed to provide highly sensitive detection of the 11 most prevalent1 ESR1 variants in plasma. The kit utilises both cell-free DNA (cfDNA) and exosomal RNA (exoRNA), which are isolated using the ExoLution Plus cfDNA + exoRNA Isolation Kit*, provided with the ESR1 exoMutation Kit. The kit offers a novel approach to achieving more meaningful breast cancer insights.
QuantideX® Haematology Portfolio
QuantideX® Haematology Portfolio
The QuantideX portfolio features multiplex, singleton design, so the target and reference genes are detected together, with only one reaction required per sample (minus controls & calibrators). The portfolio includes the first Class C IVDR-certified chronic myeloid leukaemia assay for BCR-ABL Major breakpoints, a BCR-ABL minor Kit†, a PML-RARA Kit* and a new JAK2 Kit*.
1. PLoS One. 2020 May 6;15(5):e0231999.
*For Research Use only. Not for use in diagnostic procedures
†CE-IVD